Biologic Activities of the pertusis toxin B-pentamer
Biologic Activities of the pertusis toxin B-pentamer
批准号:
7371627
负责人:
WILLIAM E MILLER
金额:
$35.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 2011-08-31
关键词:
AcuteAffectApoptosisAttenuatedBindingBinding SitesBiochemicalBiological ModelsBordetella pertussisCD4/CD8 ratio procedureCXCR4 geneCell CommunicationCell DeathCell LineCell ProliferationCell Surface ProteinsCell Surface ReceptorsCellsCessation of lifeChemokine (C-C Motif) Receptor 5ChemotaxisComplexCytoplasmDevelopmentDiseaseElementsEventHIV InfectionsHealthcareHeterotrimeric GTP-Binding ProteinsHumanImmune responseImmune systemIn VitroIncidenceIndividualInfectionLeukocyte TraffickingLeukocytesLigandsLymphocyteMediatingMolecularMusMutationPertussisPertussis ToxinPertussis VaccinePhenotypePublishingReceptor SignalingRegulationReportingResourcesRoleSelectinsSignal PathwaySignal TransductionSplenocyteStudy SectionT-LymphocyteTherapeuticToxic effectToxinUnited StatesVaccinatedVaccinesVirulence Factorschemokinechemokine receptorcombatcrosslinkdesensitizationimprovedin vivoinsightmigrationmutantpertussis toxin receptorpreferencereceptorreceptor bindingresponse
中文摘要
描述(由申请人提供):百日咳毒素(PTX)是一种复杂的AB5毒素,由酶活性的“a”亚基(S1)和结合的“B”寡聚物(PTX-B)组成,由5个亚基S2、S3、S4和S5组成,比例为1:1:2:1。AB毒素的B部分将A亚基转运到靶细胞的细胞质中,不被认为参与毒性作用。然而,PTX-B已被证明除了促进S1进入细胞质的作用外还具有活性。PTX-B诱导一系列细胞反应,包括细胞立即死亡、细胞凋亡、细胞聚集,甚至细胞增殖。在本提案中,我们将鉴定PTX-B的受体,我们将利用T细胞作为模型系统表征受PTX-B结合影响的信号通路,我们将表征其对免疫系统其他细胞的毒性。
英文摘要
DESCRIPTION (provided by applicant): Pertussis toxin (PTX) is a complex AB5 toxin, comprised of the enzymatically active, "A" subunit (S1), and the binding, "B" oligomer (PTX-B), composed of five subunits S2, S3, S4, and S5, found in a 1:1:2:1 ratio. The B portions of AB toxins transport the A subunit to the cytoplasm of target cells, and were not thought to participate in toxicity. However PTX-B has been shown to have activity in addition to its role in facilitating entry of S1 into the cytoplasm. PTX-B induces a spectrum of cellular responses, including immediate cell death, development of apoptosis, cellular clustering, and even cellular proliferation. In this proposal we will identify the receptors for PTX-B, we will characterize the signaling pathways that are affected by binding of PTX-B using T cells as a model system, and we will characterize its toxicity to other cells of the immune system.
Specific Aim 1. Characterization of the PTX-B binding elements. PTX-B has been shown to bind to multiple receptors on cells. We will identify the essential PTX-B binding regions as a prelude to the identification of potential cell surface receptors.
Specific Aim 2. Determine the mechanism by which PTX-B attenuates chemokine receptor signaling and chemotaxis. The mechanism by which PTX-B affects chemokine receptor activity remains largely unknown. We will extend our studies on the mechanism(s) of PTX-B signaling in T-cells to determine if PTX-B blocks lymphocyte migration by promoting chemokine receptor desensitization using the chemokine receptor CCR5 as a model system.
Specific Aim 3. Characterize the ability of primary cells to respond to intact pertussis toxin and PTX-B. Published reports suggest that the responses to PTX-B are different between mice and humans. We propose to characterize the short term and long-term responses of human and murine leukocytes both intact pertussis toxin and PTX-B.
Pertussis toxin is the major virulence factor of Bordetella pertussis, the causative agent of human whooping cough or pertussis. Whooping cough is common, endemic, and consumes a significant amount of health care resources, and is the only vaccine-preventable disease that is increasing in incidence in the United States. B. pertussis is able to infect previously infected or vaccinated individuals due to its ability to impede the development of a protective immune response, and understanding the interaction of pertussis toxin with the immune system is important for developing improved pertussis vaccines and therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of the role of HDAC activity in regulation of HCMV replication in the salivary epithelium
-
批准号:10739852
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2023
-
负责人:WILLIAM E MILLER
-
依托单位:
Mechanisms of vGPCR mediated Cytomegalovirus Growth in the Salivary Gland
-
批准号:10180884
-
项目类别:
-
资助金额:$40.11万
-
财政年份:2018
-
负责人:WILLIAM E MILLER
-
依托单位:
Development of salisphere-derived systems for the study of cytomegalovirus vGPCR directed viral growth in the salivary gland
-
批准号:9317077
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2017
-
负责人:WILLIAM E MILLER
-
依托单位:
Mechanisms of vGPCR mediated Cytomegalovirus Growth in the Salivary Gland
-
批准号:9332531
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2016
-
负责人:WILLIAM E MILLER
-
依托单位:
Role of Cytomegalovirus GPCRs in Pathogenesis in Vivo
-
批准号:8514752
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2012
-
负责人:WILLIAM E MILLER
-
依托单位:
HCMV US28 Signal Transduction by Betaarrestin proteins
-
批准号:7068459
-
项目类别:
-
资助金额:$26.23万
-
财政年份:2005
-
负责人:WILLIAM E MILLER
-
依托单位:
HCMV US28 Signal Transduction by Betaarrestin proteins
-
批准号:7371077
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2005
-
负责人:WILLIAM E MILLER
-
依托单位:
HCMV US28 Signal Transduction by Betaarrestin proteins
-
批准号:6987737
-
项目类别:
-
资助金额:$22.83万
-
财政年份:2005
-
负责人:WILLIAM E MILLER
-
依托单位:
HCMV US28 Signal Transduction by Betaarrestin proteins
-
批准号:7188515
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2005
-
负责人:WILLIAM E MILLER
-
依托单位:
HCMV US28 Signal Transduction by Betaarrestin proteins
-
批准号:7582343
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2005
-
负责人:WILLIAM E MILLER
-
依托单位:
Environmental Carcinogenesis and Mutagenesis
-
批准号:10189584
-
项目类别:
-
资助金额:$54.87万
-
财政年份:1988
-
负责人:WILLIAM E MILLER
-
依托单位:
Environmental Carcinogenesis and Mutagenesis
-
批准号:10630963
-
项目类别:
-
资助金额:$60.27万
-
财政年份:1988
-
负责人:WILLIAM E MILLER
-
依托单位:
Environmental Carcinogenesis and Mutagenesis
-
批准号:10415926
-
项目类别:
-
资助金额:$71.14万
-
财政年份:1988
-
负责人:WILLIAM E MILLER
-
依托单位:
Biologic Activities of the pertusis toxin B-pentamer
-
批准号:7662109
-
项目类别:
-
资助金额:$35.1万
-
财政年份:1986
-
负责人:WILLIAM E MILLER
-
依托单位:
Biologic Activities of the pertusis toxin B-pentamer
-
批准号:7924036
-
项目类别:
-
资助金额:$35.33万
-
财政年份:1986
-
负责人:WILLIAM E MILLER
-
依托单位:
PHARMACOKINETICS OF INTRAPLEURAL AND INTRAPERITONEAL CISPLATIN
-
批准号:4703668
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:WILLIAM E MILLER
-
依托单位:
PHARMACOKINETICS OF INTRAPLEURAL AND INTRAPERITONEAL CISPLATIN
-
批准号:3976123
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:WILLIAM E MILLER
-
依托单位:
海外基金